India to South Africa: Capecitabine Export Trade Route
India has recorded 47 verified shipments of Capecitabine exported to South Africa, representing a combined trade value of $943.4K USD. This corridor is served by 7 active Indian exporters, with an average shipment value of $20.1K USD. The leading Indian exporter is INTAS PHARMACEUTICALS LIMITED, which accounts for 47% of total export value with 32 shipments worth $445.2K USD. On the buying side, Accord Healthcare c/o Qestmed (PTY) is the largest importer in South Africa with $275.9K USD in purchases. The top 3 suppliers — INTAS PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LIMITED , SUN PHARMACEUTICAL INDUSTRIES LIMITED — together control 90% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.

Route Intelligence Overview
The India to South Africa Capecitabine corridor is one of India's established pharmaceutical export routes, with 47 shipments documented worth a combined $943.4K USD. The route is dominated by INTAS PHARMACEUTICALS LIMITED, which alone accounts for roughly 47% of all export value, reflecting the consolidated nature of India's capecitabine manufacturing sector.
Across 7 active suppliers, the average shipment value stands at $20.1K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 71% of all shipments, consistent with capecitabine's non-urgent bulk-order profile.
Shipment activity peaks during July–September, with an average transit time of 27 days port-to-port. The route has recorded an annual growth rate of 27.7%, placing it at rank #1 among India's top capecitabine export destinations globally.
On the import side, key buyers of Indian capecitabine in South Africa include Accord Healthcare c/o Qestmed (PTY) , ACCORD HEALTHCARE C/O QESTMED, ACCORD HEALTHCARE C/O QESTMED (PTY) and 9 others. Accord Healthcare c/o Qestmed (PTY) is the single largest importer with 4 shipments valued at $275.9K USD.
Route Characteristics
- Average transit27 days
- Peak seasonQ3
- Primary modeSea freight
- Top portSAHAR AIR
Market Position
- Global rank#1
- Annual growth+27.7%
- Demand growth+25.1%
- Regulatory ease73/100
Top 10 Indian Capecitabine Exporters to South Africa
Showing top 10 of 7 Indian suppliers exporting Capecitabine to South Africa, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | INTAS PHARMACEUTICALS LIMITED Avg $13.9K per shipment | 32 | $445.2K | 47.2% |
| 2 | INTAS PHARMACEUTICALS LIMITED Avg $62.5K per shipment | 5 | $312.6K | 33.1% |
| 3 | SUN PHARMACEUTICAL INDUSTRIES LIMITED Avg $44.1K per shipment | 2 | $88.3K | 9.4% |
| 4 | CIPLA LIMITED Avg $39.2K per shipment | 1 | $39.2K | 4.2% |
| 5 | EUGIA PHARMA SPECIALITIES LIMITED Avg $14.6K per shipment | 2 | $29.2K | 3.1% |
| 6 | CIPLA LIMITED Avg $6.6K per shipment | 4 | $26.4K | 2.8% |
| 7 | BIOZENTA LIFESCIENCE PRIVATE LIMITED Avg $2.4K per shipment | 1 | $2.4K | 0.3% |
This table shows the top 10 of 7 Indian companies exporting capecitabine to South Africa, ranked by total trade value. The listed exporters are: INTAS PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LIMITED , SUN PHARMACEUTICAL INDUSTRIES LIMITED, CIPLA LIMITED , EUGIA PHARMA SPECIALITIES LIMITED, CIPLA LIMITED, BIOZENTA LIFESCIENCE PRIVATE LIMITED. INTAS PHARMACEUTICALS LIMITED is the dominant supplier with 32 shipments worth $445.2K USD, giving it a 47% market share. The top 3 suppliers together account for 90% of the total trade value on this route.
Top 10 Capecitabine Importers in South Africa
Showing top 10 of 12 known buyers in South Africa receiving Capecitabine shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian capecitabine in South Africa include Accord Healthcare c/o Qestmed (PTY) , ACCORD HEALTHCARE C/O QESTMED, ACCORD HEALTHCARE C/O QESTMED (PTY), RANBAXY PHARMACEUTICALS PTY LIMITED, TO THE ORDER.,, among 12 total buyers. The largest importer is Accord Healthcare c/o Qestmed (PTY) , accounting for $275.9K USD across 4 shipments — representing 29% of all capecitabine imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | Accord Healthcare c/o Qestmed (PTY) | 4 | $275.9K | 29.2% |
| 2 | ACCORD HEALTHCARE C/O QESTMED | 16 | $235.0K | 24.9% |
| 3 | ACCORD HEALTHCARE C/O QESTMED (PTY) | 11 | $153.8K | 16.3% |
| 4 | RANBAXY PHARMACEUTICALS PTY LIMITED | 2 | $88.3K | 9.4% |
| 5 | TO THE ORDER., | 4 | $45.8K | 4.9% |
| 6 | MEDPRO PHARMACEUTICA (PTY) LTD, | 1 | $39.2K | 4.2% |
| 7 | Accord Healthcare c/o Qestmed | 1 | $36.7K | 3.9% |
| 8 | AUROGEN SOUTH AFRICA (PTY) LTD, | 2 | $29.2K | 3.1% |
| 9 | MEDPRO PHARMACEUTICA PTY LIMITED | 3 | $20.0K | 2.1% |
| 10 | ACCORD HEALTHCARE C/O QESTMED PTY L | 1 | $10.6K | 1.1% |
Showing top 10 of 12 Capecitabine importers in South Africa on this route.
Top 10 Capecitabine Formulations Imported by South Africa
Showing top 10 of 24 product formulations shipped on the India to South Africa Capecitabine route, ranked by trade value
South Africa imports a wide range of capecitabine formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — PHARMA DRUGS & MEDI CAPEXA CAPECITABINE — accounts for $275.9K USD across 4 shipments. There are 24 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | PHARMA DRUGS & MEDI CAPEXA CAPECITABINE | 4 | $275.9K | 29.2% |
| 2 | PHARMACEUTICAL DRUGS & MEDICINE CAPEXA CAPECITABINE 500MG 12X10T(ACC-SA EACH FILM COATED TABLET CONTS:CAPECITABINE 500MGTBS | 6 | $120.5K | 12.8% |
| 3 | PHARMA DRUGS & MEDI CAPEXA CAPECITABINE500 MG 12X10T(ACC-SA AS PER INVOICE | 3 | $119.3K | 12.6% |
| 4 | CAXETA TAB 500MG 120S SA CAPECITABINE TABLETS 500 MGPACK : 12*10 SAP CODE : 1156105 HSN CODE : 30049049 | 2 | $88.3K | 9.4% |
| 5 | CAPELODA TABLET (CAPECITABINE 500 MG) (7 | 1 | $39.2K | 4.2% |
| 6 | PHARMACEUTICAL DRUGS & MEDICINE CAPEXA CAPECITABINE 500MG 12X10T(ACC-SA EACH FILM COATED TABLET CONT.CAPECITABINE 500MGTBS | 3 | $38.2K | 4.0% |
| 7 | PHARMA DRUGS AND MEDI CAPEXA CAPECITABINE 500 MG 12X10T AS PER INV | 3 | $37.9K | 4.0% |
| 8 | PHARMA DRUG&MED:CAPEXA CAPECITABINE 150 | 1 | $36.7K | 3.9% |
| 9 | PHARMA DRUGS AND MEDI CAPEXA CAPECITABINE 500 MG 12X10T(ACC-SA) EACH FILM COATEDTABLET CONTAINS:CAPECITABINE 500MG | 1 | $29.7K | 3.1% |
| 10 | CAPECITABINE TABLETS 500MG (Capecitabine Tablets 500 mg AUROXEDA -120S BLISTER PACK)(1003 PACK'S) | 1 | $24.0K | 2.5% |
Showing top 10 of 24 Capecitabine formulations imported by South Africa on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 71%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
SAHAR AIR handles the highest volume with 13 shipments. Transit time averages 27 days by sea.
Market Dynamics
India's capecitabine exports to South Africa are driven primarily by a handful of large-scale manufacturers. INTAS PHARMACEUTICALS LIMITED with 32 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 7 active exporters signals a competitive but concentrated market — buyers in South Africa benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — INTAS PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LIMITED , SUN PHARMACEUTICAL INDUSTRIES LIMITED — together account for 90% of total trade value on this route. The average shipment value of $20.1K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as pharmaceutical drugs & medicine capexa capecitabine 500mg 12x10t(acc-sa each film coated tablet conts:capecitabine 500mgtbs and pharma drugs & medi capexa capecitabine500 mg 12x10t(acc-sa as per invoice, suggesting that buyers in South Africa tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, Accord Healthcare c/o Qestmed (PTY) is the largest importer with 4 shipments worth $275.9K USD — representing 29% of all capecitabine imports from India on this route. A total of 12 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $943.4K
- Avg. Shipment
- $20.1K
- Suppliers
- 7
- Buyers
- 12
- Transit (Sea)
- ~27 days
- Annual Growth
- +27.7%
Related Analysis
Other Capecitabine Routes
Unlock the Full India to South Africa Capecitabine Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 47 shipments on this route.
Frequently Asked Questions — India to South Africa Capecitabine Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Capecitabine to South Africa?
The leading Indian exporters of Capecitabine to South Africa are INTAS PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LIMITED , SUN PHARMACEUTICAL INDUSTRIES LIMITED. INTAS PHARMACEUTICALS LIMITED holds the largest market share at approximately 47% of total trade value on this route.
Q What is the total value of Capecitabine exports from India to South Africa?
India exports Capecitabine to South Africa worth approximately $943.4K USD across 47 recorded shipments. The average value per shipment is $20.1K USD.
Q Which ports does India use to ship Capecitabine to South Africa?
The most active port of origin is SAHAR AIR with 13 shipments. Indian exporters primarily use sea freight for this route, with 71% of shipments going by sea and 20% by air.
Q How long does shipping take from India to South Africa for Capecitabine?
The average transit time for Capecitabine shipments from India to South Africa is approximately 27 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during July–September.
Q Is the India to South Africa Capecitabine trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 27.7% with demand growth tracking at 25.1%. The route is ranked #1 among India's top Capecitabine export destinations globally.
Q How many suppliers are active on the India to South Africa Capecitabine route?
There are currently 7 active Indian suppliers exporting Capecitabine to South Africa. The market is moderately concentrated with INTAS PHARMACEUTICALS LIMITED accounting for 47% of total shipment value.
Q Who are the main importers of Capecitabine from India in South Africa?
The leading importers of Indian Capecitabine in South Africa include Accord Healthcare c/o Qestmed (PTY) , ACCORD HEALTHCARE C/O QESTMED, ACCORD HEALTHCARE C/O QESTMED (PTY), RANBAXY PHARMACEUTICALS PTY LIMITED, TO THE ORDER.,. Accord Healthcare c/o Qestmed (PTY) is the largest buyer with 4 shipments worth $275.9K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to South Africa export trade corridor identified from Indian Customs (DGFT) records for Capecitabine.
- 2.Supplier/Buyer Matching: 7 Indian exporters and 12 importers in South Africa matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 47 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
47 Verified Shipments
7 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists